Analysis of HFRS vaccination against hemorrhagic fever with renal syndrome during 1999-2000 in Laiwu City.
- Author:
Kaixiao WEI
1
;
Yifeng XIE
;
Zhanfeng YAO
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Aged; Child; Female; Hantaan virus; immunology; Hemorrhagic Fever with Renal Syndrome; prevention & control; Humans; Male; Middle Aged; Vaccination; Vaccines, Inactivated; Viral Vaccines
- From: Chinese Journal of Experimental and Clinical Virology 2002;16(3):283-285
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the effect the vaccine of hemorrhagic fever with renal syndrome (HFRS).
METHODSData of totally, 1095 individuals who were immunized with HFRS vaccine type produced by Shenyang Baiao Biotechnology, Ltd were analyzed. 1999-2000 in Laiwu City.
RESULTSMost of the individuals belonged to rural population. In most cases the vaccination was done in spring and autumn. Persons between ages 18-40 years dominated the series. The side effects of the vaccination were seen in 1.71% in which local reaction was 1.35%, general reaction 0.30%, abnormal reaction 0.06% and the lowest reaction rate was seen in the group between ages 7-17.
CONCLUSIONSThe vaccine was quite effective. Both antibody positive ratio and GMT level of antibody were high.
